Miwon Chemical (134380) 2026 stock outlook for US investors. Surfactants, sulfonic acid and sulfuric derivatives, a low-PER and dividend value case, a roughly $26K daily trading volume trap, spread risk and what to track each quarter.
Daejung Chemicals & Metals (KOSDAQ 120240) stock outlook for 2026. A qualitative look at the lab reagent cash cow, the high-barrier semiconductor process chemical bet, customer qualification moats, front-end chip capex sensitivity, peers like Dongjin Semichem, and the deep-value case for a foreign investor.
SQM (Sociedad Quimica y Minera de Chile) 2026 stock outlook: Atacama brine cost-curve moat, the Codelco partnership through 2060, lithium price cycle, iodine and specialty plant nutrition, risks, and a US investor's tax angle.
HWKN (Hawkins) stock outlook for 2026: water treatment chemical distribution and manufacturing, the three-segment mix, a serial bolt-on acquisition model past $1B in revenue, pricing power, dividend record, peer comparison and risks.
NGVT Ingevity stock outlook for 2026: how wood-based activated carbon dominates gasoline vapor canisters, why hybrids soften the EV hit, what crude tall oil does to chemical margins, and how debt and portfolio pruning shape the thesis.
Balchem (BCPC) 2026 stock analysis: microencapsulation moat, choline and mineral nutrition segments, steady margins, bolt-on acquisition compounding, input-cost exposure, premium valuation and small-cap liquidity risks.
IOSP Innospec stock outlook for 2026: how a small specialty chemicals company earns its keep in fuel additives, why the net-cash balance sheet matters for bolt-on M&A, where the oilfield segment can hurt, and what to watch each quarter.
Element Solutions (ESI) 2026 stock analysis: the specialty-chemistry moat behind semiconductor assembly and advanced packaging, why the Solstice divestiture fell through and what that re-rating means, plus commodity-input risk, peer comparison, and metrics to watch.
A 2026 outlook on Green Chemical (KRX: 083420), the sole domestic South Korean producer of ETA specialty amine used in CO2 capture solvents, covering its defensive surfactant cash-flow base, carbon-capture policy optionality, feedstock spread risk, peer comparison, and how foreign investors can approach a small-cap Kosdaq chemical name.
KWR (Quaker Houghton) stock outlook for 2026. A close look at the global leader in metalworking fluids and industrial process fluids, its switching-cost moat built into customer manufacturing lines, revenue tied to steel and auto production volumes, the 2019 merger integration, and raw material spread risk.
A qualitative 2026 outlook on CBT (Cabot Corporation), the world's largest carbon black producer, covering its tire-reinforcement cash engine, lithium-ion battery conductive carbon and carbon nanotube growth, dividend policy, and China oversupply risk.
H.B. Fuller (FUL) 2026 stock outlook. A deep qualitative look at its global top-three position in industrial adhesives, the specialty-mix margin story, bolt-on M&A strategy, raw-material spread and industrial demand cyclicality, and a 55-plus-year dividend growth record.
ASH (Ashland) 2026 stock outlook, analyzed qualitatively. Pharmaceutical excipients, personal care ingredients, and coatings additives across the Life Sciences, Personal Care, Specialty Additives, and Intermediates segments, plus the high-margin specialty pivot, dividends, buybacks, and competition from IFF, Croda, and Evonik.
Korea Alcohol Industrial (KOSDAQ 017890) 2026 stock outlook. A qualitative deep dive into the protected soju-ethanol oligopoly, ethyl acetate and anhydrous ethanol cyclicality, grain and molasses cost pass-through, and the bioethanol optionality for foreign investors.
Hannong Chemicals (011500) stock outlook for 2026. A qualitative deep dive into its surfactant and glycol-ether core business, functional monomers and glyme expansion, the solid-state battery electrolyte-material option, small-cap volatility, and valuation-overheat risk.
NEU (NewMarket) stock outlook 2026. A deep qualitative look at the Afton and Ethyl lubricant and fuel additive oligopoly, the OEM-approval moat, the cash-generative buyback compounder model, the long-run electric-vehicle demand risk, and the AMPAC defense-materials diversification.
Miwon Commercial (002840) stock outlook 2026. A deep qualitative look at the high-mix, low-volume specialty surfactant compounder model, its cosmetics and electronic-materials demand, feedstock spread cycles, the confusion with Miwon Holdings and Miwon SC, plus foreign-investor tax and KRW currency risk.
Chemtros (220260) 2026 stock outlook. A deep qualitative look at this KOSDAQ specialty-chemicals maker: semiconductor and display electronic materials, UV-curable resins, functional additives, the spec-in moat behind materials localization, and the customer-concentration, cyclicality, and small-cap liquidity risks a foreign investor buying a Korean equity should weigh.
Miwon Specialty Chemical (KOSDAQ 268280) 2026 stock outlook for foreign investors. UV/EB photocure oligomer and monomer moat, coatings and electronics revenue model, display and semiconductor materials localization growth option, feedstock and demand-cycle risk, holding-company governance, and KRW currency exposure analyzed in depth.
CC (Chemours) 2026 stock outlook. A committed, qualitative deep dive on the structural growth of Opteon low-GWP refrigerants, the commodity cyclicality of TiO2 titanium pigment, the fluoropolymers franchise, and the PFAS forever-chemicals litigation and remediation liabilities that hang over the shares.
Dongsung Chemical (102260) stock outlook for 2026. A deep qualitative look at its polyurethane systems, TPU and polyol business, footwear-brand demand, the push into bio-based eco polyols, and the commodity-margin and feedstock volatility that keep it a cyclical chemical name.
HUN (Huntsman Corporation) stock outlook for 2026. A deep qualitative look at the polyurethanes MDI, Performance Products, and Advanced Materials segments, the chemical downcycle trough thesis, Chinese overcapacity, high European energy costs, dividend durability and the real risk of a cut, plus recovery leverage.
Isu Chemical (KRX 005950) 2026 stock outlook. A deep qualitative look at its LAB detergent-feedstock cash cow, integrated sulfur and thiol chemistry moat, the lithium sulfide (Li2S) solid-state battery electrolyte growth option, and the commodity-spread cycle, oil, solid-state timing, FX, and affiliate governance risks that drive the shares.
A frank 2026 analysis of Avantor (AVTR). We break down the spec-in consumables moat in bioprocessing and ultra-high-purity chemicals, the Lab Solutions distribution versus Bioscience Production split, post-destocking demand recovery, the leverage that shapes the story, cost-out execution, and how AVTR stacks up against Thermo, Danaher, Sartorius, and Repligen.